157 related articles for article (PubMed ID: 30023066)
1. The impact of a history of cancer on pancreatic ductal adenocarcinoma survival.
He X; Li Y; Su T; Lai S; Wu W; Chen L; Si J; Sun L
United European Gastroenterol J; 2018 Jul; 6(6):888-894. PubMed ID: 30023066
[TBL] [Abstract][Full Text] [Related]
2. Impact of Prior Malignancy on Survival Outcomes of Stage IV Pancreatic Adenocarcinoma: SEER-Based Cohort.
Al-Husseini MJ; Saad AM; Turk T; Tabash MA; Abdel-Rahman O
J Gastrointest Cancer; 2019 Dec; 50(4):794-800. PubMed ID: 30105523
[TBL] [Abstract][Full Text] [Related]
3. Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis.
He C; Zhang Y; Cai Z; Lin X
BMC Cancer; 2019 May; 19(1):509. PubMed ID: 31142278
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a competing risk model for second primary pancreatic ductal adenocarcinoma: A population-based study.
Song L; Xu C; Zhang T; Chen S; Shi Z; Hu S; Cheng B; Tong H; Wei G; Li X
Front Surg; 2022; 9():934148. PubMed ID: 36111234
[TBL] [Abstract][Full Text] [Related]
5. Impact of prior cancer history on the overall survival of younger patients with lung cancer.
Liu J; Zhou H; Zhang Y; Fang W; Yang Y; Hong S; Chen G; Zhao S; Chen X; Zhang Z; Xian W; Shen J; Huang Y; Zhao H; Zhang L
ESMO Open; 2020 Feb; 5(1):. PubMed ID: 32054633
[TBL] [Abstract][Full Text] [Related]
6. Effect of prior malignancy on the prognosis of gastric cancer and somatic mutation.
Yin X; He XK; Wu LY; Yan SX
World J Clin Cases; 2022 Feb; 10(5):1485-1497. PubMed ID: 35211586
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
Bian X; He X; Yang L; Wu W; Li L
Dig Dis Sci; 2020 Jul; 65(7):2140-2147. PubMed ID: 31673904
[TBL] [Abstract][Full Text] [Related]
8. Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma.
Li YF; Xiang YC; Zhang QQ; Wang WL
J Gastrointest Oncol; 2020 Aug; 11(4):644-653. PubMed ID: 32953148
[TBL] [Abstract][Full Text] [Related]
9. Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis.
Yang A; Zylberberg HM; Rustgi SD; Amin SP; Bar-Mashiah A; Boffetta P; Lucas AL
Sci Rep; 2021 Jan; 11(1):1038. PubMed ID: 33441781
[TBL] [Abstract][Full Text] [Related]
10. The Impact of a History of Different Other Cancers on the Long-Term Outcomes of Patients with Gallbladder Cancer: A Propensity Score-Adjusted, Population-Based Study.
Wang J; Zhang C; Yan D
Technol Cancer Res Treat; 2023; 22():15330338231183937. PubMed ID: 37394878
[TBL] [Abstract][Full Text] [Related]
11. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
12. Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria.
Al-Husseini MJ; Saad AM; Mohamed HH; Alkhayat MA; Sonbol MB; Abdel-Rahman O
BMC Cancer; 2019 Aug; 19(1):863. PubMed ID: 31470823
[TBL] [Abstract][Full Text] [Related]
13. Does Prior Cancer Have an Influence on the Survival Outcomes of Patients with Localized Pancreatic Neuroendocrine Tumors?
Wang L; Li G; Bing YT; Tian ML; Wang HY; Yuan CH; Xiu DR
Chin Med Sci J; 2021 Dec; 36(4):284-294. PubMed ID: 34986965
[TBL] [Abstract][Full Text] [Related]
14. The Impact of a History of Different Other Cancers on the Long-Term Outcomes of Patients with Intrahepatic Cholangiocarcinoma: A Population-Based Analysis.
Chai J; Kong J; Zhu K
Biomed Res Int; 2022; 2022():3970884. PubMed ID: 35257009
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis of patients with primary breast duct carcinoma and lung adenocarcinoma: a population-based study from SEER.
Lv F; Cheng M; Jiang L; Zhao X
Sci Rep; 2021 Jul; 11(1):14790. PubMed ID: 34285322
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of male lung cancer patients with urinary cancer: a study from a national population-based analysis.
Li W; Cheng M; Hu P; Jiang L; Zhao X
Sci Rep; 2023 Jan; 13(1):283. PubMed ID: 36609573
[TBL] [Abstract][Full Text] [Related]
17. Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry.
Lu TP; Wu CH; Chang CC; Chan HC; Chattopadhyay A; Lee WC; Chiang CJ; Lee HY; Tien YW
Ann Surg Oncol; 2022 Mar; 29(3):1608-1615. PubMed ID: 34775547
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database.
Luo C; Fan L; Lun W; Ma M; Liang L; Yu C
J Chemother; 2024 Apr; 36(2):167-178. PubMed ID: 38481380
[TBL] [Abstract][Full Text] [Related]
19. The impact of a prior malignancy on outcomes in gastric cancer patients.
Bian X; Wang K; Wang Q; Yang L; Xia J; Wu W; Li L
Cancer Med; 2021 Feb; 10(4):1457-1470. PubMed ID: 33470048
[TBL] [Abstract][Full Text] [Related]
20. Does a history of malignancy impact the survival of a subsequent endometrial adenocarcinoma? Should clinical trials eligibility criteria be revisited?
Mohamed HH; Ibrahim Sokkar M; Afifi AM; Saad AM; Albarouki S; Al-Husseini MJ
J Obstet Gynaecol; 2020 Feb; 40(2):233-239. PubMed ID: 31352852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
